Metraipolis › archive › dc_261a73f98952

Tocilizumab combined with short-term high-dose glucocorticoids for rapid disease activity control and glucocorticoid reduction in adult-onset Still's disease:… — Europe PMC PMID:41727458

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41727458
DOI
10.3389/fimmu.2026.1732826
License (as archived)
solo-consultazione
Archived
2026-11-06T02:20:15.919Z
SHA-256 of the archived text
747ad63b7faa43c9a3d554d0aa88098ff0a3ec52d37ee54e10373088668e4f25
Stable URL of this page
https://metraipolis.com/documento/dc_261a73f98952

How to cite

Tocilizumab combined with short-term high-dose glucocorticoids for rapid disease activity control and glucocorticoid reduction in adult-onset Still's disease:… — Europe PMC PMID:41727458 — Europe PMC (en), https://europepmc.org/article/MED/41727458 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_261a73f98952 (Metraipolis archive dc_261a73f98952, sha256 747ad63b7faa43c9a3d554d0aa88098ff0a3ec52d37ee54e10373088668e4f25)
BibTeX
@misc{dc261a73f98952,
  title = {Tocilizumab combined with short-term high-dose glucocorticoids for rapid disease activity control and glucocorticoid reduction in adult-onset Still's disease:… — Europe PMC PMID:41727458},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41727458},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_261a73f98952; sha256 747ad63b7faa43c9a3d554d0aa88098ff0a3ec52d37ee54e10373088668e4f25},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41727458. Agents can read the archived copy with the MCP tool read_document.